Status:
COMPLETED
A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males
Lead Sponsor:
Pfizer
Conditions:
Healthy
Eligibility:
MALE
18-55 years
Phase:
PHASE1
Brief Summary
To determine how the body reacts to a low dose of PF-06427878 when given in a vein over 30 minutes to healthy, adult, males.
Eligibility Criteria
Inclusion
- Healthy male subjects between 18-55 years of age
- BMI of 17.5-30.5 kg/m2
Exclusion
- History of drug or alcohol abuse within 2 years of screening
- Subjects without suitable veins for multiple venipuncture/cannulation
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT02237742
Start Date
November 1 2014
End Date
December 1 2014
Last Update
November 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Quotient Clinical Ltd
Ruddington, Nottingham, United Kingdom, NG11 6JS